Global and United States Animal Stem Cell Therapy Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and United States Animal Stem Cell Therapy Market Report & Forecast 2024-2034
Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Market Analysis and InsightsGlobal and United States Animal Stem Cell Therapy Market
This report focuses on global and United States Animal Stem Cell Therapy market, also covers the segmentation data of other regions in regional level and county level.
The global Animal Stem Cell Therapy revenue was US$ 203.8 million in 2022 and is forecast to a readjusted size of US$ 482.9 million by 2029 with a CAGR of 12.8% during the review period (2024-2034).
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Global Animal Stem Cell Therapy Scope and Market Size
Animal Stem Cell Therapy market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Animal Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For United States market, this report focuses on the Animal Stem Cell Therapy market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Veterinary Hospitals
Research Organizations
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Animal Stem Cell Therapy definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Animal Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Stem Cell Therapy revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States Animal Stem Cell Therapy Market
This report focuses on global and United States Animal Stem Cell Therapy market, also covers the segmentation data of other regions in regional level and county level.
The global Animal Stem Cell Therapy revenue was US$ 203.8 million in 2022 and is forecast to a readjusted size of US$ 482.9 million by 2029 with a CAGR of 12.8% during the review period (2024-2034).
Global 5 largest manufacturers of Animal Stem Cell Therapy are Ardent Animal Health, VetStem, Medrego, Animal General and Magellan Stem Cells, which make up over 17%. Among them, Ardent Animal Health is the leader with about 6% market share.
Asia Pacific is the largest market, with a share about 50%, followed by North America and Europe, with the share about 26% and 24%. In terms of product type, Dogs Stem Cell Therapy occupies the largest share of the total market, about 47%. And in terms of application, the largest application is Veterinary Hospitals, followed by Research Organizations.
Global Animal Stem Cell Therapy Scope and Market Size
Animal Stem Cell Therapy market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Animal Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For United States market, this report focuses on the Animal Stem Cell Therapy market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.
By Company
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel
Segment by Type
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Segment by Application
Veterinary Hospitals
Research Organizations
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Animal Stem Cell Therapy definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Animal Stem Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Animal Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Stem Cell Therapy revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices